Biotech Values

[mid_swe]

>>No, that’s not the point. It’s quite plausible that Squalamine could be efficacious in AMD at 40mg but not at 10-20mg.<<

In Post #57 you wrote:

"Slide 52: Efficacy at 4 months stratified by dose. This is an especially important slide because it suggests that the 50mg/m2 dose did not work appreciably better than the 25mg/m2 dose:"

If I compare the result from the 6 pts treated it´s the same as the old trial at 25 and 50mg/m2 dose.

"Preliminary results from six patients treated with 40 mg of squalamine, each of whom suffered from wet AMD in both eyes, demonstrated that of 100% of eyes (n=12) had preserved or improved vision at week three"

As I see it they are more or less confirming the old results but I´m not sure if there is a difference in dose schedule.